2023 Mammary Gland Biology Gordon Research Conference and Gordon Research Seminar

项目总结 戈登乳腺生物学研究会议(GRC MGB)和非常成功的戈登 伴随这次会议的研究研讨会(GRS)在基础生物学和乳腺癌中是独一无二的 会议，因为他们聚集了不同的科学家和临床医生-对分子感兴趣的科学家 以及控制正常乳腺发育、哺乳生理、肿瘤启动、 以及进展和转移。人们非常关注正常和乳腺癌的基本机制。 生物学和治疗(基于阐明导致乳腺癌发病和死亡的早期和晚期事件 进展)和与该领域相关的新兴“尖端”科学。GRC MGB/GRS是唯一 会议的重点是利用来自正常乳腺生物学和生理学的见解来理解 导致乳腺癌的事件，并已成为乳腺生物学家和癌症医生必须参加的活动 世界各地的研究人员(特别是基础和翻译研究领域的研究人员)。2023年的具体目标 GRC/GRS将提供一个项目，解决该领域的关键科学问题和争议。这个 2023年会议将聚焦于乳腺生物学领域的最新发现和悬而未决的问题 对乳腺癌的预防和治疗以及对人类 哺乳与婴儿健康。国际专家已被确认将讨论(1)表型主题 以及个人化治疗的遗传方法。(2)绘制正常和患病状态图。(3)营养素 正常和癌症的代谢调节。(4)正常生物的激素和系统调节 癌症。(5)正常生物和疾病中的微生物与炎症。(6)微环境调控 发育、功能和癌症。(7)正常生物学和癌症中的免疫调节。(8)表观遗传学和 正常生物学和癌症过程中的可塑性。(9)生活方式、遗传因素与乳腺癌病因。

Project SUMMARY The Gordon Research Conference on Mammary Gland Biology (GRC MGB) and the highly successful Gordon Research Seminar (GRS) that accompanies this meeting are unique amongst basic biology and breast cancer conferences as they bring together a diverse mix of scientists and clinician-scientists interested in the molecular and cellular mechanisms that govern normal mammary gland development, lactation physiology, tumor initiation, and progression and metastasis. There is a strong focus on basic mechanisms of normal and breast cancer biology and treatment (based on elucidating the early and later events that contribute to breast cancer onset and progression) and emerging `cutting edge' science relevant to the field. The GRC MGB/GRS is the only conference focused on harnessing insights from normal mammary gland biology and physiology to understand events that give rise to breast cancer and has become a `must attend' for mammary gland biologists and cancer researchers (particularly in basic and translational research areas) the world over. The Specific Aims of the 2023 GRC/GRS are to deliver a program that addresses critical scientific questions and controversies in the field. The 2023 conference will focus on recent discoveries and outstanding questions in the mammary gland biology field that have immediate and long-term relevance to breast cancer prevention and treatment as well as human lactation and infant health. International experts have been confirmed to address the topics of (1) Phenotypic and genetic approaches for personalization of treatment. (2) Mapping normal and diseased states. (3) Nutrients and metabolism regulation of normal and cancer. (4) Hormones and systemic regulation of normal biology and cancer. (5) Microbiome and inflammation in normal biology and disease. (6) Microenvironment modulation of development, function, and cancer. (7) Immune modulation in normal biology and cancer. (8) Epigenetics and plasticity during normal biology and cancer. (9) Lifestyle and genetic factors and breast cancer etiology.